-2-
more
Historical Non-GAAP Financial Information
The tables accompanying this release provide recast operating income by segment, non-GAAP diluted EPS and Adjusted EBITDA for 2024,
2025 and the first nine months of 2026. The recast information reflects the exclusion of acquisition-related remeasurement gains from the Company’s
non-GAAP results and is being provided to facilitate comparison of financial performance across periods. The change has no impact on the Company’s
historical GAAP financial statements.
Adjustments to 2026 GAAP Net Income and Diluted EPS
The Company is providing guidance for 2026 diluted EPS and for 2026
Adjusted EBITDA on a non-GAAP basis, as noted above. The
Company is not providing a reconciliation of its 2026 non-GAAP diluted EPS guidance to its projected 2026 diluted EPS prepared on a GAAP basis, or
its 2026 Adjusted EBITDA guidance to net income prepared on a GAAP basis. This is because the Company is unable to provide without unreasonable
effort an estimate of restructuring expenses and related costs, including its ongoing value-creation initiatives, and the corresponding tax effect, which will
be included in the Company’s 2026 diluted EPS and net income, prepared on a GAAP basis. The inability to provide this reconciliation is due to the
uncertainty and inherent difficulty of predicting the occurrence, magnitude, financial impact and timing of related costs.
Management does not believe these items are representative of the Company’s underlying business performance. For the same reasons, the
Company is unable to address the probable significance of the unavailable information, which could be material to future results.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for health care customers. With approximately
25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than
300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology and Supply Chain solutions help
office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental
laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and
Henry Schein corporate brand products in our main distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y.,
and has operations or
affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately
11.0 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com.
Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information
In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary
remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations
and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of
future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual
results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or
implied by such forward-looking statements.
These statements include total sales growth, EPS and Adjusted EBITDA guidance and statements about our business expectations, and are
generally identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to
be,” “to make” or other comparable terms. A fuller discussion of our operations, financial condition and status of litigation matters, including factors that
may affect our business and future prospects, is contained in documents we file with the United States Securities and Exchange Commission, or SEC,
including our Annual Report on Form 10-K, and will be contained in subsequent periodic filings we make with the SEC. These documents identify in
detail important risk factors that could cause our actual performance to differ materially from current expectations.
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited
to: our dependence on third parties for the manufacture and supply of our products and where we manufacture products, our dependence on third parties
for raw materials or purchased components; risks relating to the achievement of our strategic growth objectives, including anticipated results of
restructuring and value creation initiatives; risks related to the Strategic Partnership Agreement with KKR Hawaii Aggregator L.P. entered into in
January 2025; transitions in senior company leadership, (including, without limitation, our Chief Executive Officer, Chief Financial Officer, and other
executive officers); our ability to develop or acquire and maintain and protect new products (particularly technology and specialty products) and services
and utilize new technologies that achieve market acceptance with acceptable margins; transitional challenges associated with acquisitions and joint
ventures, including the failure to achieve anticipated synergies/benefits, as well as significant demands on our operations, information systems, legal,